Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
about
p53 and microRNA-34 are suppressors of canonical Wnt signaling.Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survivalIntegrative analysis of neuroblastoma and pheochromocytoma genomics data.A robust method for estimating gene expression states using Affymetrix microarray probe level dataInactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells.The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.Ultra-High Density SNParray in Neuroblastoma Molecular DiagnosticsGenome-wide Mapping of Copy Number Variations Using SNP Arrays.Integrative genomics in combination with RNA interference identifies prognostic and functionally relevant gene targets for oral squamous cell carcinoma.Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundant.A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition.Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria.Integrated genomic analysis of sézary syndromeMapping complex disease traits with global gene expression.Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridizationGenome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT.International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeALK gene copy number gain and its clinical significance in hepatocellular carcinoma.Molecular characterization and classification of neuroblastoma.Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.Identification of SNP-containing regulatory motifs in the myelodysplastic syndromes model using SNP arrays and gene expression arrays.Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression.Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors.Identification of a putative transcriptome signature common to neuroblastoma and neural crest cells.Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16.CHL1 gene acts as a tumor suppressor in human neuroblastoma.Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11qUse of genome-wide high-throughput technologies in biomarker development
P2860
Q30424916-B9809032-D20E-4D6F-AA3D-43EC71F774C8Q30495169-9F9EDDA2-4B64-4526-920C-1B5D8557F7C2Q30575178-67D6C4F9-FC62-48F7-AADC-2DDE2B1C68C5Q33551524-91E22FB0-9170-4AE4-BF7D-9712078828E4Q33578581-13BC8F5D-2A9D-41F7-98D3-A8CDEABC8F9AQ33761692-D84A2568-8506-4BF4-A0E8-58C2A12C982AQ33882364-CC73267E-A8FC-4E7F-AB8D-DC943985117FQ34032495-F7A5554D-6C4B-429D-8922-9A542D0B49D7Q34139304-A4FBC4BF-8E26-49C4-8EFF-2DA81EC4862EQ34558023-D28BFC3A-7E30-4E1A-B493-A4A96CFB3F71Q34711056-A3D07937-937C-4CBD-B113-91598CCF65C0Q35493751-528A07E4-130B-4138-80B3-D8D4096EC2A7Q35503722-931FE420-037E-481F-BDA8-459C603348FDQ35832304-81BA5F32-D410-4CFB-9D43-87C21B06D878Q35910314-34FDAE76-082E-4141-A958-C702C02FB52AQ35997212-5A149D42-C88D-464E-8028-E9CC9A48C6D8Q36357428-8B3756FE-9E30-4739-9CC8-D8E20D042010Q36378134-02180317-9701-4D64-9C6C-84EAEF42A438Q36437048-D38B0136-E874-41DD-A895-B17F0FFD815DQ37003304-FF36E00B-1A7A-4C2E-A237-472823875B4DQ37222603-228EFE61-A979-411B-99E3-1D62539E7F84Q37454444-4873AC9D-9A21-4BC1-B869-312941C60A0EQ37515355-391F0FB2-AA94-4F8F-90C8-AFF3E59E1AACQ37939996-CFC9BBDD-4C07-4411-84F0-05E5C53C45FDQ38318420-CDF12A55-C043-4259-8333-34FB435E9B6EQ42777743-23A9C2AB-BBA8-4F04-B7AF-D4AC1D7F96BEQ50853134-9ADA4040-6594-49D5-A72C-E4A02FD14C95Q51803860-32E87B47-58D5-49F4-B2EC-7655928DEDD9Q52870427-8319F96D-4CBB-4ABC-AF3C-34589770D791Q55039402-F40EC21A-D245-4EBD-907D-9F26F67648E1Q57270554-E30D5C8E-AFC0-4F53-80F1-5F87371E6984Q57556407-7D402751-FD0B-49D1-A3A1-CDDAFCE04261
P2860
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Identification of candidate ge ...... icroarrays with survival data.
@ast
Identification of candidate ge ...... icroarrays with survival data.
@en
type
label
Identification of candidate ge ...... icroarrays with survival data.
@ast
Identification of candidate ge ...... icroarrays with survival data.
@en
prefLabel
Identification of candidate ge ...... icroarrays with survival data.
@ast
Identification of candidate ge ...... icroarrays with survival data.
@en
P2093
P356
P1433
P1476
Identification of candidate ge ...... microarrays with survival data
@en
P2093
A D J Pearson
C Cullinane
D A Tweddle
M Santibanez-Koref
S A Burchill
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210552
P407
P577
2007-05-28T00:00:00Z
P6179
1048829291